Effects of oestrogen on vulvovaginal candidosis

Mycoses. 2022 Jan;65(1):4-12. doi: 10.1111/myc.13385. Epub 2021 Nov 25.

Abstract

As a frequently occurring infectious disease mainly caused by Candida albicans, vulvovaginal candidosis (VVC) affects more than 100 million women worldwide every year. Multiple factors that influence C. albicans colonisation have been linked to the incidence of VVC, including high levels of circulating oestrogen due to pregnancy, the use of oral contraceptives, and hormone replacement therapy. This review provides an overview of the current understanding of the mechanism(s) by which oestrogen contributes to VVC, which might provide meaningful guidance to the prevention and treatment of this disease.

Keywords: Candida albicans; neutrophils; oestrogen; virulence; vulvovaginal candidosis.

Publication types

  • Review

MeSH terms

  • Candida
  • Candida albicans
  • Candidiasis, Vulvovaginal*
  • Estrogens / adverse effects
  • Estrogens / blood*
  • Female
  • Humans
  • Incidence
  • Pregnancy

Substances

  • Estrogens